Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Current Assets (2016 - 2026)

Nrc Health's Current Assets history spans 16 years, with the latest figure at $20.2 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 3.11% to $20.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.2 million, a 3.11% increase, with the full-year FY2025 number at $20.2 million, up 3.11% from a year prior.
  • Current Assets hit $20.2 million in Q4 2025 for Nrc Health, down from $20.4 million in the prior quarter.
  • Over the last five years, Current Assets for NRC hit a ceiling of $73.7 million in Q4 2021 and a floor of $17.0 million in Q2 2024.
  • Historically, Current Assets has averaged $39.4 million across 5 years, with a median of $33.2 million in 2023.
  • Biggest five-year swings in Current Assets: skyrocketed 84.18% in 2021 and later tumbled 58.65% in 2024.
  • Tracing NRC's Current Assets over 5 years: stood at $73.7 million in 2021, then plummeted by 40.69% to $43.7 million in 2022, then tumbled by 44.28% to $24.4 million in 2023, then decreased by 19.54% to $19.6 million in 2024, then grew by 3.11% to $20.2 million in 2025.
  • Business Quant data shows Current Assets for NRC at $20.2 million in Q4 2025, $20.4 million in Q3 2025, and $25.3 million in Q2 2025.